OXOS Medical Proposes Deployable Chest X-Ray Device for Coronavirus Diagnoses and Monitoring
OXOS Medical is responding to the National Science Foundation’s (NSF) call for proposals for specialized equipment to be considered under the Rapid Response Research (RAPID) funding mechanism to develop processes and actions to address the global coronavirus/COVID-19 pandemic.
Founded in 2016 as Micro C Imaging LLC in Savannah, Georgia by two graduates of Georgia Tech, the company, now called OXOS, also has operations in Atlanta. It is a startup in the Advanced Technology Development Center’s ATDC Accelerate portfolio of companies.
OXOS developed the world first handheld dynamic digital radiography device for orthopedic surgery. The team soon realized the advantages and opportunities for adjacent care and it now provides fast, safe and high-quality radiographic imaging at the point of care in both surgical and clinical settings. It’s advanced technology design also offers cloud-connection, giving providers instant access to the information they need, using high-resolution imagery.
While its Micro C handheld X-ray device is its lead product, OXOS has expanded its scope as a developer of advanced orthopedic imaging devices and software.
“In consultation with pulmonologists, anesthesiologists, and surgeons, OXOS has determined that having an easily deployable chest X-ray would be critical for the management of the COVID-19 pandemic,” said Dr. Gregory Kolovich, an orthopedic hand and micro-surgeon who is OXOS co-founder and chief medical officer. “We could provide a portable, in-home method to aid in diagnosing, monitoring, and clinical decision making.”